Published in

Springer Nature [academic journals on nature.com], Leukemia, 12(37), p. 2497-2501, 2023

DOI: 10.1038/s41375-023-02027-3

Links

Tools

Export citation

Search in Google Scholar

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO